Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Influenza Medications Market

Influenza Medications Market Share

Report ID: GMI8695
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Influenza Medications Market Share

The influenza medications industry is characterized by the existence of several key players competing to meet the demand for effective treatments and preventive measures against influenza. The market players are continuously involved in innovation, collaboration, and new product launches to maintain a competitive edge in the market.

Influenza Medications Market Companies

Leading firms operating in the influenza medications industry include:

AstraZeneca plc
Teva Pharmaceutical Industries Ltd
BioCryst Pharmaceuticals, Inc.
Sanofi
Daiichi Sankyo Company
Novartis AG
F. Hoffmann-La Roche AG
NATCO Pharma Limited
GlaxoSmithKline plc
Lupin

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Influenza medications market size was USD 942.6 million in 2023 and is expected to register 2.9% CAGR from 2024-2032 owing to the increasing prevalence of influenza worldwide.

Influenza medications industry from the antiviral drugs segment generated USD 520.3 million in 2023 and is expected to register 3.4% CAGR from 2024-2032 due to being considered as the primary treatment for influenza infections.

North America influenza medications industry size is expected to reach USD 548.7 million by 2032 due to a significant burden of influenza infections annually, along with population density, international travel, and seasonal variations.

AstraZeneca plc, BioCryst Pharmaceuticals, Inc., Daiichi Sankyo Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Lupin, NATCO Pharma Limited, Novartis AG, Sanofi, and Teva Pharmaceutical Industries Ltd., are some of the major influenza medications companies worldwide.